Atlas Trials

Real World Data Collection Pediatric Neuroblastoma Treated With Lorlatinib

Clinical trial NCT04753658 · TERMINATED

Trial details

NCT number
NCT04753658
Sponsor
Pfizer
Status
TERMINATED
Study type
OBSERVATIONAL
Neuroblastoma
Start date
2021-03-19
Primary completion
2022-09-30
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.